货号: CL-0133
Price: ¥1600 ¥1600
生长培养基: DMEM/F12[PM150312]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | KLE(人子宫内膜癌细胞) |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:DMEM/F12[PM150312]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | KLE细胞是源自一名64岁白人女性的子宫内膜肿瘤组织,由G·R·Richardson于1984年建系。KLE细胞染色体为非整倍体,数目范围在51-66之间。KLE细胞裸鼠植瘤后,其肿瘤标本在电镜下显示,细胞间见紧密相连,细胞表面具有微绒毛。KLE细胞形态特征与孕激素刺激后的子宫内膜相似。 |
年龄(性别) | 64Y Female |
组织来源 | 子宫;子宫内膜 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 子宫内膜腺癌细胞 |
生物安全等级 | BSL-1 |
致瘤性 | Yes, Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 1×10<sup>7</sup> cells. |
STR位点信息
STR鉴定图
-
Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling(2024)
作者:Lin Yibin, Chen Xiao, Lin Linping, Xu Benhua, Zhu Xiaofeng, Lin Xian
期刊:CELLULAR & MOLECULAR BIOLOGY LETTERS
DOI:10.1186/s11658-024-00583-9
影响因子:9.2
引用产品: Ishikawa 细胞, KLE 细胞
-
TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigens(2024)
作者:Daosheng Huang, Yi Li, Wei Rui, Keyong Sun, Zhixiao Zhou, Xiachen Lv, Li Yu, Junfan Chen, Jing Zhou, Vincent Liu, Jiasheng Wang, Xun Lan, Yang-Xin Fu, Xueqiang Zhao, Xin Lin
期刊:Cell Reports
DOI:10.1016/j.celrep.2024.114949
影响因子:7.5
引用产品: SK-BR-3 [SKBR3] 细胞, KLE 细胞
-
HMGB1-mediated transcriptional activation of circadian gene TIMELESS contributes to endometrial cancer progression through Wnt-β-catenin pathway(2024)
作者:Zhaoxia Wang, Simin He, Liqing Xin, Ying Zhou, Le Zhao, Fuyuan Wang
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2024.111045
影响因子:4.8
引用产品: Ishikawa 细胞, KLE 细胞, Ishikawa细胞专用培养基, KLE细胞专用培养基
-
Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p/S100A4 axis(2024)
作者:Wei Ren, Ling Ouyang
期刊:ENVIRONMENTAL TOXICOLOGY
影响因子:4.4
引用产品: 人子宫内膜上皮细胞, HEC-1-A 细胞, KLE 细胞, Ishikawa 细胞, RL95-2 细胞
-
Lactamase β reprograms lipid metabolism to inhibit the progression of endometrial cancer through attenuating MDM2-mediated p53 ubiquitination and degradation(2024)
作者:Ting Zhou, Xiaorong Li, Fangfang Zhao, Jing Zhou, Binghui Sun
期刊:ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
影响因子:3.8
引用产品: RL95-2 细胞, HEC-1-A 细胞, Ishikawa 细胞, AN3 CA 细胞, KLE 细胞
-
Participation of Long Noncoding RNA FOXP4-AS1 in the Development and Progression of Endometrioid Carcinoma with Epigenetically Silencing DUSP5(2024)
作者:Leilei Liu, Jingyun Zhao, Hui Guo, Jingde Jia, Li Shi, Jing Ma, Zhengmao Zhang
期刊:CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
影响因子:2.4
引用产品: KLE 细胞, RL95-2 细胞, Ishikawa 细胞
-
Activation of MAL2 by RAD21 inhibits the expression of MHC-I in immune evasion of endometrial cancer(2024)
作者:Jin Yuni, Lu Xiaoning, Liu Yuan, Su Liangdi, Bao Chan, Guo Huiming
期刊:CYTOTECHNOLOGY
DOI:10.1007/s10616-024-00629-y
影响因子:2.2
引用产品: HEC-1-A 细胞, KLE 细胞
-
Asparanin A exerts cytotoxicity on human endometrial cancer Ishikawa cells via regulating miR-6236-p5_4 expression(2023)
作者:Fan Zhang, Xiu-Xiu Zhang, Jian-Guo Zhang, Kiran Thakur, Jesus Simal-Gandara, Miguel A. Prieto, Mohammad Rizwan Khan, Hui Cao, Zhao-Jun Wei
期刊:FOOD AND CHEMICAL TOXICOLOGY
影响因子:4.3
引用产品: KLE 细胞
-
Novel insights into tumorigenesis and prognosis of endometrial cancer through systematic investigation and validation on mitophagy-related signature(2023)
作者:Sun Rui, Zhou Xiaoyu, Wang Tong, Liu Yao, Wei Lina, Qiu Ziyi, Qiu Chunping, Jiang Jie
期刊:Human Cell
DOI:10.1007/s13577-023-00920-8
影响因子:4.3
引用产品: KLE 细胞
-
Inhibition of ATM with KU-55933 Sensitizes Endometrial Cancer Cell Lines to Olaparib(2023)
作者:Anqing Zhang, Liqin Zhang, Xia Xie, Dan Liu
期刊:OncoTargets and Therapy
影响因子:4.0
引用产品: Ishikawa 细胞, HEC-1-B 细胞, AN3 CA 细胞, KLE 细胞, RL95-2 细胞
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图